Leukaemia Immunotherapy Group

The Immunotherapy and Graft-versus-Leukaemia (GVL) Research Group is lead by Dr Agnes Yong. The group investigates the mechanisms of inherent immunogenicity of haematological malignancies, and immune responses against leukaemia. This includes studies of T cell responses against tumour-associated antigens in patients with Chronic Myeloid Leukemia (CML), multiple myeloma (MM) and Myelodysplastic syndrome (MDS), and in patients who have received allogeneic stem cell transplantation. The research program is furthering cellular and immunotherapy for leukaemia treatment, including the development of chimeric antigen receptor (CAR) T cell therapy for myeloid leukaemia.

Get in touch
+61 8 8128 4000 info@sahmri.com
You can't miss us!
North Terrace Adelaide 5000 South Australia
Postal Address
PO BOX 11060 Adelaide 5001 South Australia
Key Partners
SAHMRI is located on the traditional lands of the Kaurna Nation.

The SAHMRI community acknowledges and respects the traditional owners, the family clans who are the Kaurna Nation from the Adelaide Plains region of South Australia. We acknowledge the clans of the Kaurna Nation and the sacred knowledge they hold for their country. We pay our respects to the Kaurna Nation, their ancestors and the descendants of these living family clans today.